glp-1 covered by medicare CMS Expands Access to Medications for Beneficiaries Medicare is covering GLP-1 weight

Renal Elimination: Sitagliptin is not extensively metabolized by the liver enzymes cytochrome P450 3A4 and 2C8

Cost Comparison Table Insurance Coverage Saxenda: FDA-approved for weight loss Some plans cover with prior authorization May have quantity limits or step therapy requirements Ozempic: FDA-approved for diabetes, not weight loss Often covered for diabetic patients Rarely covered for weight loss alone Wegovy: FDA-approved for weight loss Coverage varies widely Many plans exclude weight loss medications Cost Efficiency When comparing cost per outcome: Saxenda: At $200/month for 12 months ($2,400) producing 15-18 pounds loss = ~$133-160 per pound lost Semaglutide: At $199/month for 12 months ($2,388) producing 30-35 pounds loss = ~$68-80 per pound lost Semaglutide provides substantially better value when considering weight loss achieved per dollar spent

3 Therefore, the prevention of acute exacerbation is an important strategy to reduce lung function decline, improve quality of life and eventually reduce COPD mortality

Because I've talked about peptides a couple times on the show, once long ago with Dr Rand M, another time with Christian Gem

Full visibility of the products moving through the network provides stakeholders with real-time data analytics, offering assurance of where these medications are being stored and distributed throughout the supply chain